DaVita Clinical Research
825 South 8th Street
Minneapolis, Minnesota 55404
888-345-2567 http://www.dcrmn.com Halcorn@dcrmn.com

Use our guide to learn which trials are right for you!

DaVita Clinical Research (DCR) is a full-service Phase I-IV renal clinical trial site and Site Management Organization. A subsidiary of DaVita, Inc., one of the largest providers of dialysis services in the United States, DCR has over 15 years of experience as a recognized leader in renal clinical trials for pharmaceutical drugs and devices. DCR is a private trial site located in Minneapolis, MN, with access to many local and national patient populations. Nationally, DCR has access to over 400 dialysis facilities and over 38,000 end-stage renal disease patients.

DaVita Clinical Research is committed to the success of customer's studies, by providing uncompromising quality and timely, cost-effective professional services. DCR is unique, providing Phase I-IV renal clinical trials/510(k) approval capabilities, quick local IRB approval, rapid enrollment of patients, and Board Certified physicians committed to quality management of all protocol research activities in areas such as:

  • End-Stage Renal Disease (ESRD)
  • Renal Insufficiency

Since 1983, DCR has conducted clinical trials for the following sponsors:

  • Abbott Labs
  • Abgenix, Inc.
  • Alpha-Beta Technology
  • Alquest, Inc.
  • Alteon Inc.
  • American Cyanamid Company
  • Amgen Inc.
  • Amylin Pharmaceuticals, Inc.
  • AstraZeneca Pharmaceuticals
  • Aventis
  • Baxter Healthcare Corporation
  • Bayer
  • Berlex Laboratories, Inc.
  • Biogen
  • Bracco Diagnostics, Inc.
  • Bristol-Myers Squibb
  • Cato Research
  • Cellegy Pharmaceuticals
  • Centocor, Inc.
  • Chugai-Upjohn, Inc.
  • Colgate
  • Corgentech, Inc.
  • Covance Inc.
  • Cubist Pharmaceuticals
  • Diatide Research Laboratories
  • Discovery Therapeutics
  • Du Pont Merck
  • Eisai America, Inc.
  • Elan
  • Eli Lilly & Company
  • Empherse
  • Ethicon, Inc.
  • Fujisawa
  • Genzyme Corporation
  • GH Besselaar Associates
  • GlaxoSmithKline
  • Hoffmann-LaRoche
  • Idenix Pharmaceuticals
  • Ingenix, Inc.
  • Intercardia, Inc.
  • Janus
  • Liposome Company

  • Mallinkrodt Medical Inc.
  • Maret
  • Medi-Ject Corporation
  • Merck
  • MGI Pharma, Inc.
  • Miles, Inc.
  • Myogen
  • Nabi Biopharmaceuticals
  • National Institute of Health
  • National Kidney Foundation of the Upper Midwest
  • Neurex Inc.
  • Neurocrine Biosciences
  • NeuroMed Technologies, Inc.
  • Novartis
  • Omnicare, Inc.
  • Orphan Medical
  • Ortho Biotech
  • Parke-Davis
  • Pfizer Inc.
  • Pharmacia
  • Pharmaquest for R&D Laboratories, Inc.
  • PharmaNet
  • PPD, Inc.
  • PRA International
  • Proctor & Gamble Co.
  • RPR, Inc.
  • Roche Laboratories
  • Sandoz Research Institute
  • Schein Pharmaceutical Company
  • Schering-Plough Research Institute
  • Scios, Inc.
  • Smith Kline Beecham Pharmaceuticals
  • Syntex Research
  • Takeda America Inc.
  • TAP Pharmaceuticals
  • Texas Biotechnology Corporation
  • University of Minnesota
  • UTI Med
  • Versicor
  • Wyeth-Ayerst
  • Yamanouchi Pharmaceutical Co., Ltd.

Suzanne K. Swan, M.D.
Medical Director of the Clinical Research Unit of DCR; Associate Professor, School of Medicine, University of Minnesota; Board Certified in Internal Medicine, Nephrology, and Clinical Pharmacology; Staff Nephrologist, Division of Nephrology, Hennepin County Medical Center. Research interests are clinical pharmacology of drugs in renal failure, aminoglycoside nephrotoxicity, mechanisms of protection from nephrotoxins, and diuretic pharmacokinetics/pharmacodynamics.

Harry Alcorn, Jr., Pharm.D.
Chief Scientific Officer, DaVita Clinical Research; Adjunct Clinical Professor, College of Pharmacy, University of Minnesota. His responsibilities include management for local and National operations for clinical research for DCR and DaVita, Inc.

Cardiology/Vascular Diseases
Dermatology/Plastic Surgery
Immunology/Infectious Diseases

Our center features:

  • 55 beds for patient confinement
  • Recreational amenities
  • 24-hour medical coverage
  • Private client monitor rooms
  • Four exam rooms and two large treatment rooms
  • Outpatient blood draw area
  • Sample processing laboratory
  • Freezers (-70 degree Celsius and -20 degree Celsius)
  • Refrigerated centrifuges
  • Computerized EKG machines
  • Laminar flow hood for IV preparation
  • Telemetry capabilities
  • Access to hemodialysis units
  • Registered dietitian consultant
  • Specialty meals
  • Affiliation with two CLIA certified clinical laboratories

DCR's headquarters and phase I unit are located in Downtown Minneapolis, MN, adjacent to Hennepin County Medical Center. We are a ten-minute drive from Minneapolis/St. Paul International Airport.

Harry Alcorn Jr. PharmD., Chief Scientific Officer;
DaVita Clinical Research
825 South 8th Street, Suite 300
Minneapolis, MN 55404
866-852-3241 (fax)

We've found
6 trials
at this facility
Gastroenterology Clinical Trial
Effect of Hepatic Impairment on LDK378 Pharmacokinetics
Status: Enrolling, Phase I
Updated: 3/3/2016
Minneapolis, MN
Click here to add this to my saved trials
Gout Clinical Trial
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling, Phase I
Updated: 1/6/2016
Minneapolis, MN
Click here to add this to my saved trials
Hepatic Impairment Clinical Trial
A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.
Status: Enrolling, Phase I
Updated: 12/31/1969
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling, Phase II
Updated: 12/31/1969
Minneapolis, MN
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer
Status: Enrolling, Phase I
Updated: 1/4/2016
Minneapolis, MN
Click here to add this to my saved trials
Renal Dialysis Clinical Trial
End-stage Renal Disease (ESRD) Pilot Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Minneapolis, MN
Click here to add this to my saved trials